Riskpilot← Back to searchSign inGet full accessTrochlearis AB
ABActiveOrg 5591668511Göransbergsvägen 27General medical practice activities · NACE 8621Est. 20181 employees
Revenue 2025
SEK 402K
-59% vs 2024
EBITDA margin
-13.4%
-113% vs 2024
Equity ratio
90.0%
Financial strength
Net profit 2025
SEK 1K
-100% vs 2024
| Revenue | SEK 402K | -59% |
| EBITDA | SEK -54K | -113% |
| Net profit | SEK 1K | -100% |
| Total assets | SEK 2,6M | -14% |
| Equity | SEK 2,4M | -8% |
| Employees | 1 | — |
Legal name
Trochlearis AB
Org number
5591668511
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 juli 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företagets verksamhet är försäkringsmedicinsk konsultverksamhet, rådgivning (intyg) till försäkringskassor, försäkringsbolag o.d. Företaget ska också hyra ut egen personal som läkare, dels till sjukhus med såväl öppen som sluten somatisk sjukvård, dels till specialistmottagningar (ej sjukhus) samt bedriva förvaltning av och handel med värdepapper, för en begränsad och sluten krets av ägare.
Address
Göransbergsvägen 27
Email
nina@hagwall.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 011 | 1 417 | 1 351 | 980 | 402 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 484 | 487 | 313 | 414 | −54 |
| Depreciation & amort. | −5 | −5 | −5 | −5 | −0 |
| EBIT | 479 | 482 | 308 | 409 | −54 |
| Net financials | — | 3 | 7 | 79 | 36 |
| Profit before tax | 479 | 486 | 315 | 518 | 2 |
| Tax | −99 | −101 | −66 | −110 | −1 |
| Net profit | 380 | 385 | 249 | 408 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 809 | 3 035 | 2 842 | 3 071 | 2 647 |
| Equity | 2 305 | 2 506 | 2 373 | 2 582 | 2 383 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 303 | 329 | 269 | 319 | 115 |
| Total debt | 303 | 329 | 269 | 319 | 115 |
EBITDA margin
-13.4%
This company
15.8%
Market median
-185% vs market
20212025
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Trochlearis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fred Maurice Hagvall | Deputy Board Member | 0 companies |
| Nina Ingegerd Hagvall | Board of Directors | 0 companies |